Postherpetic neuralgia
Information
- Disease name
- Postherpetic neuralgia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06232486 | Active, not recruiting | Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia. | December 1, 2023 | December 31, 2026 | |
| NCT00168441 | Completed | Phase 2 | A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia | June 2004 | June 2005 |
| NCT00238511 | Completed | Phase 2 | An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN) | November 2002 | January 2005 |
| NCT00478179 | Completed | Phase 2 | Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia | September 2006 | December 2007 |
| NCT00492323 | Completed | Phase 2 | An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). | March 2007 | June 2008 |
| NCT04099706 | Completed | N/A | Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A RCT | September 19, 2019 | October 1, 2021 |
| NCT01251211 | Completed | Phase 4 | Botulinum Toxin in Peripheral Neuropathic Pain | October 2010 | January 2014 |
| NCT01302275 | Completed | Phase 4 | Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain | February 2011 | May 2013 |
| NCT01318226 | Completed | Phase 2 | Study to Evaluate the Safety and Analgesic Activity of ATx08-001 in Subjects With Postherpetic Neuralgia | March 2011 | July 2011 |
| NCT01379716 | Completed | N/A | Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls | January 2011 | June 2013 |
| NCT01508676 | Completed | N/A | Effects of Pennsaid on Clinical Neuropathic Pain | November 2011 | January 2016 |
| NCT01544296 | Completed | Phase 2 | A Comparative Study of KHK6188 | February 2012 | June 2013 |
| NCT01557010 | Completed | Phase 2 | Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia | March 2012 | December 2013 |
| NCT01596491 | Completed | Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain | April 2011 | November 2012 | |
| NCT01688947 | Completed | Phase 2 | Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) | September 2012 | April 2014 |
| NCT01757873 | Completed | Phase 2 | Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia | December 2012 | November 2013 |
| NCT02228928 | Completed | Phase 1/Phase 2 | Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain | February 2009 | May 2011 |
| NCT02336555 | Completed | Phase 1 | The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012) | March 12, 2015 | February 29, 2016 |
| NCT02365636 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN) | February 26, 2015 | May 9, 2017 |
| NCT03708653 | Completed | Single Nucleotide Polymorphisms (SNPs) Associated With Postherpetic Neuralgia | April 1, 2018 | February 13, 2019 | |
| NCT03789955 | Completed | N/A | The Superiority of Contralateral Oblique View for Mid-thoracic Epidural Assess | February 22, 2019 | November 7, 2019 |
| NCT00007501 | Completed | Phase 3 | Shingles Prevention Study | November 1998 | February 2011 |
| NCT04313335 | Completed | N/A | Duloxetine for PHN | March 1, 2021 | May 16, 2023 |
| NCT04546334 | Completed | N/A | Erector Spinae Plane Block in Post-herpetic Neuralgia | September 26, 2020 | June 19, 2021 |
| NCT04594226 | Completed | N/A | Electroacupuncture Therapy for Treating Postherpetic Neuralgia | November 11, 2020 | December 31, 2021 |
| NCT04662281 | Completed | Phase 2 | Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia | December 29, 2020 | December 21, 2022 |
| NCT04774458 | Completed | N/A | Prospective Observation of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique View | March 4, 2021 | August 31, 2022 |
| NCT04876989 | Completed | N/A | The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block | July 21, 2021 | January 16, 2023 |
| NCT05140863 | Completed | Phase 3 | To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia | November 1, 2021 | January 5, 2023 |
| NCT05208918 | Completed | N/A | Combined Application of Pulsed RF and Steroids to the DRG for PHN | February 1, 2022 | September 15, 2022 |
| NCT05357677 | Completed | Phase 2 | To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) | May 13, 2022 | January 18, 2023 |
| NCT00527202 | Completed | Phase 4 | Efficacy Study of Botox to Treat Neuropathic Pain | June 2004 | March 2007 |
| NCT00566904 | Completed | Phase 1 | New Topical Treatment for Continued Pain After Shingles | September 2006 | September 2008 |
| NCT00576108 | Completed | Phase 2 | A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) | November 2007 | July 2008 |
| NCT00599638 | Completed | Phase 2 | A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia | April 9, 2008 | December 23, 2008 |
| NCT00609323 | Completed | Phase 2 | Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN) | January 2008 | September 2008 |
| NCT00612105 | Completed | Phase 2 | Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN) | October 2007 | December 2009 |
| NCT00845923 | Completed | Phase 2 | Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia | March 2009 | October 2009 |
| NCT00861068 | Completed | Phase 2 | A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN). | February 2002 | January 2003 |
| NCT00885586 | Completed | Phase 4 | Acupuncture in Herpes Zoster Neuralgia (ACUZoster) | November 2008 | April 5, 2018 |
| NCT00904020 | Completed | Phase 4 | A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain | June 2002 | |
| NCT00904202 | Completed | Phase 4 | A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions | January 2003 | |
| NCT00916942 | Completed | Phase 2 | Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN) | June 2009 | July 2009 |
| NCT00981227 | Completed | Phase 2 | Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia | November 2007 | January 2009 |
| NCT01008553 | Completed | Phase 3 | A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome | December 2008 | March 2010 |
| NCT01106716 | Completed | Phase 2 | Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia | March 2009 | April 2010 |
| NCT01124617 | Completed | Phase 2 | A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia | June 2010 | April 2011 |
| NCT01195636 | Completed | Phase 2 | A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN) | August 2010 | March 2011 |
| NCT01228838 | Completed | Phase 2 | Study of NGX-1998 for the Treatment of Postherpetic Neuralgia | October 2010 | September 2011 |
| NCT06225960 | Enrolling by invitation | Dorsal Root Ganglion Stimulation in Postherpetic Neuropathy | August 8, 2022 | December 2025 | |
| NCT05568186 | Recruiting | Correlation Between Thermal Patterns of Infrared Thermal Imaging and Clinical Phenotype in Patients With Postherpetic Neuralgia | October 1, 2022 | October 1, 2023 | |
| NCT06420778 | Recruiting | N/A | A Randomized Controlled Study on the Treatment of Postherpetic Neuralgia in the Head and Face With Superficial Needling Combined With Electroacupuncture | January 1, 2023 | December 31, 2025 |
| NCT04560361 | Recruiting | N/A | The Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia | October 14, 2020 | October 30, 2023 |
| NCT06290661 | Recruiting | N/A | Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Postherpetic Neuralgia. | February 9, 2023 | June 30, 2025 |
| NCT04467398 | Recruiting | Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks | July 20, 2020 | June 15, 2024 | |
| NCT02412917 | Terminated | Phase 3 | A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia | June 2015 | November 2017 |
| NCT00809679 | Terminated | Phase 2 | Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia | December 2008 | June 2009 |
| NCT00352651 | Terminated | Phase 2 | Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo | June 2006 | December 2006 |
| NCT01603394 | Terminated | Phase 4 | Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia | October 2012 | June 2013 |
| NCT01744522 | Terminated | Leech Therapy for Postherpetic Neuralgia | September 2012 | April 2014 | |
| NCT01886313 | Terminated | Phase 2 | Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve | March 2014 | April 2015 |
| NCT01058642 | Terminated | Phase 2 | Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia | January 2010 | December 2010 |
| NCT01088256 | Terminated | Phase 2 | Efficacy of Etoricoxib on Peripheral Hyperalgesia | February 2011 | August 2012 |
| NCT01264237 | Unknown status | Phase 4 | Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain | March 2011 | April 2012 |
| NCT03106896 | Unknown status | Involvement of Reorganization of Cerebral Functional Connectivity in the Process of Transition to Postherpetic Neuralgia | April 2017 | June 2020 | |
| NCT02868801 | Unknown status | Phase 3 | Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia | March 2015 | June 2017 |
| NCT02737527 | Unknown status | N/A | Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block | April 2016 | November 2017 |
| NCT02597257 | Unknown status | Phase 2 | Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain | August 2015 | July 2016 |
| NCT00652184 | Unknown status | Phase 2 | Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) | March 2008 | September 2009 |
| NCT05517486 | Unknown status | Phase 1 | Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects | July 26, 2022 | May 3, 2023 |
| NCT00813826 | Unknown status | Phase 2 | Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia | January 2009 | November 2009 |
| NCT04664530 | Unknown status | Phase 4 | The Study on the Esketamine in the Treatment of Postherpetic Neuralgia | November 25, 2020 | December 1, 2023 |
| NCT01116531 | Withdrawn | Phase 4 | Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin | April 2010 | December 2012 |
| NCT00506610 | Withdrawn | Phase 2 | A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak |